Rallybio Corporation

NASDAQ:RLYB

0.395 (USD) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -57.775-74.564-66.654-47.013-26.447-17.563
Depreciation & Amortization 0.1310.150.1670.1090.0620.026
Deferred Income Tax 000000.103
Stock Based Compensation 7.99310.929.4993.6450.7040.194
Change In Working Capital -0.2584.277-0.936-3.7792.122.07
Accounts Receivables 000000
Inventory 000000
Accounts Payables -0.698-0.0990.487-0.9760.7230.728
Other Working Capital 0.444.376-1.423-2.8031.3971.342
Other Non Cash Items 0.627-1.0480.641.5051.5220.144
Operating Cash Flow -49.282-60.265-57.284-45.533-22.039-15.026
Investing Activities:
Investments In Property Plant And Equipment 0-0.012-0.054-0.333-0.137-0.188
Acquisitions Net 0-2.25-0.3-2-1.9350
Purchases Of Investments -48.933-110.664-201.316-2-1.9350
Sales Maturities Of Investments 84.425138.33489.52.0021.9370
Other Investing Activites -22.25-0.112-0.002-0.0020
Investing Cash Flow 33.49227.658-112.17-2.333-2.072-0.188
Financing Activities:
Debt Repayment 000000
Common Stock Issued 5.4050.14351.53386.2145.20531.6
Common Stock Repurchased 0.0620.2820000
Dividends Paid 000000
Other Financing Activities 00.143-0.455-3.233-0.319-0.033
Financing Cash Flow 5.1990.14351.07882.967144.88631.567
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash -10.591-32.464-118.37635.101120.77516.353
Cash At End Of Period 13.90324.49456.958175.334140.23319.458